Cite
MYOCARDIAL IMPACT OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) SECRETOMES IN CARDIO-ONCOLOGY PATIENTS.
MLA
Kwan, Jennifer, et al. “Myocardial Impact of Clonal Hematopoiesis of Indeterminate Potential (Chip) Secretomes in Cardio-Oncology Patients.” Journal of the American College of Cardiology (JACC), vol. 79, no. 9, Mar. 2022, p. 1912. EBSCOhost, https://doi.org/10.1016/S0735-1097(22)02903-5.
APA
Kwan, J., Vanoudenhove, J., Halder, S., Biancon, G., Jain, K., Chakraborty, R., Lustberg, M., Pusztai, L., Campbell, S., Zhao, H., Halene, S., & Hwa, J. (2022). Myocardial Impact of Clonal Hematopoiesis of Indeterminate Potential (Chip) Secretomes in Cardio-Oncology Patients. Journal of the American College of Cardiology (JACC), 79(9), 1912. https://doi.org/10.1016/S0735-1097(22)02903-5
Chicago
Kwan, Jennifer, Jennifer Vanoudenhove, Saiti Halder, Giulia Biancon, Kanika Jain, Raja Chakraborty, Maryam Lustberg, et al. 2022. “Myocardial Impact of Clonal Hematopoiesis of Indeterminate Potential (Chip) Secretomes in Cardio-Oncology Patients.” Journal of the American College of Cardiology (JACC) 79 (9): 1912. doi:10.1016/S0735-1097(22)02903-5.